Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

5.930 -0.010 (-0.17%)
Official Closing Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc. Common Shares

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
News headline image
Compass Pathways Goes On Bad Trip, Despite 'Positive' Results From Psilocybin Trial ↗
Shares plunged, despite a psilocybin-based drug reducing depression in a trial. 
Via Investor's Business Daily
News headline image
Cybin to Release Q2 2021 Results on November 15 ↗
Cybin (NYSE: 
Via Benzinga
News headline image
32 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Dover Motorsports, Inc. (NYSE: DVD) rose 57% to $3.58 in pre-market trading. Luminar Technologies, Inc. (NASDAQ: LAZR) rose 54.2% to $26.98 in pre-market trading after... 
Via Benzinga
News headline image
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression ↗
Cybin Inc (NYSE: CYBN), a Toronto-based biotechnology company focused on utilizing psychedelic drugs as an alternative to traditional psychiatric drugs, announced positive... 
Via Benzinga
News headline image
Cybin Inc. Receives Schedule I Manufacturing License from DEA ↗
Cybin (NYSE: 
Via Benzinga
News headline image
64 Biggest Movers From Yesterday ↗
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile... 
Via Benzinga
News headline image
Cybin's CYB003 Demonstrates Advantages over Oral Psilocybin for Mental Health ↗
Cybin (NYSE: 
Via Benzinga
News headline image
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval ↗
Detroit Decriminalizes Psychedelics 
Via Benzinga
News headline image
Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules ↗
Cybin Inc. (NYSE:CYBN) a company developing novel psychedeli... 
Via Benzinga
News headline image
Cybin Inc. Schedules R&D Briefing to Release Breakthrough Research Findings ↗
Cybin (NEO: CYBN) (NYSE: 
Via Benzinga
News headline image
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation ↗
The Week In Psychedelics: 
Via Benzinga
Topics Intellectual Property
News headline image
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex ↗
Cybin Inc. (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, announced Wednesday that the U.S. Food and Drug Administration (FDA)... 
Via Benzinga
News headline image
Cybin Inc. Announces FDA IND Authorization of Potentially Pivotal Study ↗
Cybin (NYSE: 
Via Benzinga
News headline image
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent ↗
The Week In Psychedelics 
Via Benzinga
News headline image
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? ↗
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. 
Via Talk Markets
News headline image
Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma ↗
Ronan Levy, co-founder and executive chairman of Field Trip Ltd (NASDAQ: FTRP), a company developing a network of psychedelics-assisted therapy clinics; Doug Drysdale, CEO,... 
Via Benzinga
Topics Cannabis
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
The Week In Psychedelics 
Via Benzinga
News headline image
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 ↗
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month. 
Via Talk Markets
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
News headline image
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments? ↗
This article by Jason Najum was originally published on 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 ↗
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ: 
Via Benzinga
News headline image
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference ↗
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ... 
Via Benzinga
News headline image
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio? ↗
We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses. 
Via Talk Markets
News headline image
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September ↗
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS... 
Via Benzinga
News headline image
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? ↗
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... 
Via Benzinga
News headline image
Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week? ↗
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week. 
Via Talk Markets
Topics Cannabis
News headline image
Buying Cybin Stock Right Now Could Be a Brilliant Move ↗
You'll need to be prepared for a long holding period and a hearty helping of risk. 
Via The Motley Fool
Topics Law Enforcement
News headline image
Psychedelic Drug Industry Report Card For 2021 ↗
In assessing the psychedelic drug industry, a primary focus for investors is drug development. 
Via Talk Markets
News headline image
48 Biggest Movers From Yesterday ↗
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.